State of Alaska Department of Revenue Reduces Stock Position in Mettler-Toledo International Inc. (NYSE:MTD)

State of Alaska Department of Revenue lessened its position in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 14.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,409 shares of the medical instruments supplier’s stock after selling 402 shares during the period. State of Alaska Department of Revenue’s holdings in Mettler-Toledo International were worth $2,947,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. State Street Corp increased its holdings in shares of Mettler-Toledo International by 1.0% in the 3rd quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock worth $1,431,693,000 after buying an additional 9,009 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Mettler-Toledo International by 0.8% in the 3rd quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock worth $818,906,000 after acquiring an additional 4,166 shares during the last quarter. Barclays PLC grew its holdings in shares of Mettler-Toledo International by 8.3% during the 3rd quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock valued at $384,822,000 after purchasing an additional 19,609 shares during the last quarter. JPMorgan Chase & Co. raised its position in Mettler-Toledo International by 14.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock worth $332,634,000 after purchasing an additional 28,478 shares during the period. Finally, Loomis Sayles & Co. L P lifted its stake in Mettler-Toledo International by 1.8% in the third quarter. Loomis Sayles & Co. L P now owns 209,902 shares of the medical instruments supplier’s stock worth $314,790,000 after purchasing an additional 3,644 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Stock Performance

Shares of MTD opened at $1,390.00 on Monday. The firm’s 50-day simple moving average is $1,278.92 and its two-hundred day simple moving average is $1,343.25. The stock has a market cap of $29.33 billion, a PE ratio of 34.30, a price-to-earnings-growth ratio of 4.80 and a beta of 1.13. Mettler-Toledo International Inc. has a fifty-two week low of $1,133.46 and a fifty-two week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 564.51% and a net margin of 22.29%. Equities research analysts predict that Mettler-Toledo International Inc. will post 41.94 EPS for the current year.

Insider Activity

In other news, insider Gerry Keller sold 140 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the completion of the sale, the insider now owns 6 shares of the company’s stock, valued at $7,524.54. This represents a 95.89 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.94% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently commented on MTD shares. Stifel Nicolaus decreased their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a report on Monday, November 11th. Wolfe Research initiated coverage on Mettler-Toledo International in a report on Friday, December 13th. They issued a “peer perform” rating for the company. Robert W. Baird reduced their target price on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research note on Monday, November 11th. Citigroup raised Mettler-Toledo International from a “sell” rating to a “neutral” rating and raised their price target for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Finally, Wells Fargo & Company reduced their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $1,351.25.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.